These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11338314)
1. Is drug treatment of hypertension in clinical practice as effective as in randomized controlled trials with regard to the reduction of the incidence of stroke? Klungel OH; Stricker BH; Breteler MM; Seidell JC; Psaty BM; de Boer A Epidemiology; 2001 May; 12(3):339-44. PubMed ID: 11338314 [TBL] [Abstract][Full Text] [Related]
2. Excess stroke among hypertensive men and women attributable to undertreatment of hypertension. Klungel OH; Stricker BH; Paes AH; Seidell JC; Bakker A; Voko Z; Breteler MM; Anthonius de Boer Stroke; 1999 Jul; 30(7):1312-8. PubMed ID: 10390301 [TBL] [Abstract][Full Text] [Related]
3. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154 [TBL] [Abstract][Full Text] [Related]
4. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). Perry HM; Davis BR; Price TR; Applegate WB; Fields WS; Guralnik JM; Kuller L; Pressel S; Stamler J; Probstfield JL JAMA; 2000 Jul; 284(4):465-71. PubMed ID: 10904510 [TBL] [Abstract][Full Text] [Related]
5. Effects of antihypertensive treatment in Asian populations: a meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA). Yano Y; Briasoulis A; Bakris GL; Hoshide S; Wang JG; Shimada K; Kario K J Am Soc Hypertens; 2014 Feb; 8(2):103-16. PubMed ID: 24157055 [TBL] [Abstract][Full Text] [Related]
7. [Undertreatment of hypertension and the risk of stroke in the oldest old]. Klungel OH; Stricker BH; Breteler MM; Seidell JC; de Boer A Tijdschr Gerontol Geriatr; 2000 Jun; 31(3):119-22. PubMed ID: 10900665 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial. Jönsson B; Carides GW; Burke TA; Dasbach EJ; Lindholm LH; Dahlöf B; J Hypertens; 2005 Jul; 23(7):1425-31. PubMed ID: 15942467 [TBL] [Abstract][Full Text] [Related]
10. Risk stratification for the prevention of cardiovascular complications of hypertension. Girerd X; Giral P Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258 [TBL] [Abstract][Full Text] [Related]
11. From efficacy in trials to effectiveness in clinical practice: The Swedish Stroke Prevention Study. Brunström M; Dahlström J; Lindholm LH; Lönnberg G; Hallström S; Norberg M; Nyström L; Persson M; Weinehall L; Carlberg B Blood Press; 2016 Aug; 25(4):206-11. PubMed ID: 26854107 [TBL] [Abstract][Full Text] [Related]
12. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension. Thomas GN; Chan P; Tomlinson B Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636 [TBL] [Abstract][Full Text] [Related]
13. [Preventing of stroke by antihypertensive drugs: potential and limitations]. Preobrazhenskiĭ DV; Marenitch AV; Shatunova IM; Sidorenko BA Kardiologiia; 2002; 42(6):79-85. PubMed ID: 12494136 [TBL] [Abstract][Full Text] [Related]
14. Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients. Suzuki H; Kanno Y; Hypertens Res; 2005 Apr; 28(4):307-14. PubMed ID: 16138560 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular outcome in treatment-resistant hypertension: results from the Swedish Primary Care Cardiovascular Database (SPCCD). Holmqvist L; Boström KB; Kahan T; Schiöler L; Hasselström J; Hjerpe P; Wettermark B; Manhem K J Hypertens; 2018 Feb; 36(2):402-409. PubMed ID: 28957848 [TBL] [Abstract][Full Text] [Related]
16. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study. Kizer JR; Dahlöf B; Kjeldsen SE; Julius S; Beevers G; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Wachtell K; Edelman JM; Snapinn SM; Harris KE; Devereux RB Hypertension; 2005 Jan; 45(1):46-52. PubMed ID: 15583076 [TBL] [Abstract][Full Text] [Related]
17. Association between blood pressure, the treatment of hypertension, and cardiovascular risk factors in women. Nanchahal K; Ashton WD; Wood DA J Hypertens; 2000 Jul; 18(7):833-41. PubMed ID: 10930179 [TBL] [Abstract][Full Text] [Related]
18. Importance of blood pressure control in hypertensive patients with coronary heart disease in clinical practice to reduce the risk of stroke. Barrios V; Escobar C Stroke; 2009 Jun; 40(6):e469; author reply e470. PubMed ID: 19390081 [No Abstract] [Full Text] [Related]
19. Antihypertensive medications for risk reduction of first and recurrent ischemic stroke. Padma V; Fisher M; Moonis M Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):867-76. PubMed ID: 15500432 [TBL] [Abstract][Full Text] [Related]
20. Older age should not be a barrier to the treatment of hypertension. Aronow WS Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):514-5. PubMed ID: 18607394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]